Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OCGN stock hub

Ocugen, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OCGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

511.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OCGN

In the news

Latest news · OCGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-660

P25 -105.6P50 -46.5P75 -3.1

ROIC-96.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OCGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001372299
Company name	Ocugen, Inc.
Country	United States
Country code	US
Cusip	67577C105
Employees	116
Employees Change	21%
Employees Change Percent	22.11
Enterprise value	$512.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US67577C1053
Last refreshed	2026-05-10
Market cap	$511.2M
Market cap category	Small-Cap
Price	$1.51
Price currency	USD
Rev Per Employee	38,491.38x
Sector	Healthcare
Sic	2836
Symbol	OCGN
Website	https://www.ocugen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.02%
EV/Sales	114.8x
P/B ratio	83.35x
P/S ratio	114.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-35.3M
Gross Profit Growth Q	120.58%
Net Income	$-71.7M
Net Income Growth Years	0%
Pretax Margin	-1,605.22%
Profit Per Employee	$-617,871
ROA	-68.92
Roa5y	-52.65
ROCE	-184.9
ROE	-660
Roe5y	-248.5
ROIC	-96.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	128.19%
Cagr3y	29.2%
Cagr5y	-30.31%
EPS Growth Years	0
Revenue Growth	-1.26x
Revenue Growth Q	3.51x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	15.06x
Revenue Growth5 Y	153.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.07
Assets	$56.9M
Cash	$31.9M
Current Assets	$38.6M
Current Liabilities	$20.7M
Debt	$33.3M
Debt Equity	$5.74
Equity	$5.8M
Interest Coverage	-12.74
Liabilities	$51.1M
Long Term Assets	$18.4M
Long Term Liabilities	$30.4M
Net Cash	$-1.4M
Net Cash By Market Cap	$-0.28
Net Debt Equity	$0.25
Tangible Book Value	$5.8M
Tangible Book Value Per Share	$0.02
WACC	16.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.86
Net Working Capital	$-8.2M
Quick ratio	1.54
Working Capital	$17.8M
Working Capital Turnover	$0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.86%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	128.06%
200-day SMA	1.49
3Y total return	115.71%
50-day SMA	1.86
50-day SMA vs 200-day SMA	50over200
5Y total return	-83.56%
All Time High	18.77
All Time High Change	-91.96%
All Time High Date	2021-02-08
All Time Low	0.17
All Time Low Change	788.24%
All Time Low Date	2020-06-01
ATR	0.13
Beta	2.31
Beta1y	0.6
Beta2y	1.34
Ch YTD	11.85
High	1.52
High52	2.73
High52 Date	2026-03-17
High52ch	-44.59%
Low	1.45
Low52	0.64
Low52 Date	2025-05-15
Low52ch	135.94%
Ma50ch	-18.95%
Premarket Change Percent	2.78
Premarket Price	$1.48
Premarket Volume	146,687
Price vs 200-day SMA	1.41%
RSI	39.23
RSI Monthly	52.63
RSI Weekly	48.12
Sharpe ratio	1.35x
Sortino ratio	2.31
Total Return	-9.86%
Tr YTD	11.85
Tr1m	-13.22%
Tr1w	-16.11%
Tr3m	13.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	4
Analyst Price Target Top	$9.75
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.05
Earnings Revenue Estimate	526,512x
Earnings Revenue Estimate Growth	-64.45x
Operating Income	$-66.9M
Operating margin	-1,498.7
Price target	$9.75
Price Target Change	$546
Price Target Change Top	$546

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	316,858,026%
Float Percent	93.6%
Shares Insiders	1.35%
Shares Institutions	22.26%
Shares Out	338,516,172
Shares Qo Q	2.59%
Shares Yo Y	9.86%
Short Float	21.43%
Short Ratio	7.36
Short Shares	20.06

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	8,045,246.15x
Bv Per Share	0.02
Ch1m	-13.22
Ch1w	-16.11
Ch1y	128.1
Ch3m	13.53
Ch3y	115.7
Ch5y	-83.56
Ch6m	11.03
Change	4.86%
Change From Open	0.67
Close	1.44
Days Gap	4.17
Depreciation Amortization	2,077,250
Dollar Volume	15,330,321.8
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-66.9M
EBITDA	$-64.8M
EPS	$-0.24
F Score	1
Fiscal Year End	December
Founded	2,013
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-04
Ma150	1.6
Ma150ch	-5.68%
Ma20	1.72
Ma20ch	-12.21%
Next Earnings Date	2026-07-31
Open	1.5
Optionable	Yes
Position In Range	86.67
Post Close	1.51
Postmarket Change Percent	0.66
Postmarket Price	$1.52
Ppne	13,830,000
Pre Close	1.44
Price Date	2026-05-08
Ptbv Ratio	88.06
Relative Volume	1.26x
Revenue	4,465,000x
Tr6m	11.03%
Us State	Pennsylvania
Volume	10,152,531

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OCGN pay a dividend?

Capital-return profile for this ticker.

Performance

OCGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OCGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.3%

Float: +93.6% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OCGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.2

Neutral momentum band

Price vs 200-day MA

+1.4%

50/200-day relationship not available

Beta (5Y)

2.31

More volatile than the market

Sharpe ratio

1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OCGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OCGN stock rating?

Ocugen, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OCGN analysis?

The full report lives at /stocks/OCGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OCGN?

The latest report frames OCGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OCGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.